<?xml version="1.0" ?>
<document>
  <page number="1">
    <text># Diabetes and Periodontal Diseases

Dr Leticia A Miranda &amp;amp; Dr. Pradeep Koppolu

![](L12 PerioDiabetes_figures/img_470259691384e77e.webp)</text>
    <formatted_text>Diabetes and Periodontal Diseases

Dr Leticia A Miranda &amp;amp; Dr. Pradeep Koppolu</formatted_text>
    <images>
      <img bbox="200,200,900,550" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="figure" path="L12 PerioDiabetes_figures/img_470259691384e77e.webp">
        <description>A word cloud visualization centered on the topic of diabetes. The largest and most prominent words are &amp;apos;diabetes&amp;apos;, &amp;apos;type&amp;apos;, &amp;apos;risk&amp;apos;, &amp;apos;glucose&amp;apos;, &amp;apos;insulin&amp;apos;, &amp;apos;pancreas&amp;apos;, &amp;apos;body&amp;apos;, &amp;apos;cells&amp;apos;, &amp;apos;blood&amp;apos;, &amp;apos;prevention&amp;apos;, and &amp;apos;factors&amp;apos;. Other smaller terms include &amp;apos;symptoms&amp;apos;, &amp;apos;age&amp;apos;, &amp;apos;history&amp;apos;, &amp;apos;diet&amp;apos;, &amp;apos;weight&amp;apos;, &amp;apos;gestational&amp;apos;, &amp;apos;complications&amp;apos;, &amp;apos;management&amp;apos;, and &amp;apos;treatment&amp;apos;, arranged to form a cohesive visual representation of key concepts related to diabetes.</description>
      </img>
    </images>
  </page>
  <page number="2">
    <text># Reading Resources

- **Clinical Periodontology and Implant Dentistry**, 2 Volume Set  
by Niklaus P. Lang, Jan Lindhe, and Niklaus P Lang  
**PUBLISHER**  
John Wiley &amp;amp; Sons, Incorporated  
**DATE**  
2015-03-25  

## SECTION V: CONDITIONS AFFECTING THE PERIODONTAL PATIENT  
**CHAPTER 25**  

### Influence of Systemic Conditions on the Periodontium  
*Perry R. Klokkevold | Brian L. Mealey | Yvonne L. Hernandez-Kapila*

For expanded discussions on female sex hormones, genetic disorders, and nutritional influences on periodontal disease as well as online-only content on hyperparathyroidism, anemia, thrombocytopenia, antibody deficiency disorders, and other systemic conditions, please visit the companion website at eBooks.Health.Elsevier.com.

---

**JDR Centennial Series**

### Periodontal Medicine: 100 Years of Progress  
J.D. Beck&amp;lt;sup&amp;gt;1&amp;lt;/sup&amp;gt; ID, P.N. Papapanou&amp;lt;sup&amp;gt;2&amp;lt;/sup&amp;gt;, K.H. Philips&amp;lt;sup&amp;gt;3&amp;lt;/sup&amp;gt;, and S. Offenbacher&amp;lt;sup&amp;gt;4&amp;lt;/sup&amp;gt;

Journal of Dental Research  
2019, Vol. 98(10) 1053–1062  
© International &amp;amp; American Associations for Dental Research 2019  
Article reuse guidelines:  
sagepub.com/journals-permissions  
DOI: 10.1177/0022034519846113  
journals.sagepub.com/home/jdr

![](L12 PerioDiabetes_figures/img_8ee3759f535dde89.webp)
![](L12 PerioDiabetes_figures/img_28fc506699a4e2b2.webp)
![](L12 PerioDiabetes_figures/img_840001ed316e23c6.webp)</text>
    <formatted_text>- **Clinical Periodontology and Implant Dentistry**, 2 Volume Set by Niklaus P. Lang, Jan Lindhe, and Niklaus P Lang
  - **PUBLISHER**: John Wiley &amp;amp; Sons, Incorporated
  - **DATE**: 2015-03-25

#### SECTION V: CONDITIONS AFFECTING THE PERIODONTAL PATIENT
**CHAPTER 25**

##### Influence of Systemic Conditions on the Periodontium
*Perry R. Klokkevold | Brian L. Mealey | Yvonne L. Hernandez-Kapila*

For expanded discussions on female sex hormones, genetic disorders, and nutritional influences on periodontal disease as well as online-only content on hyperparathyroidism, anemia, thrombocytopenia, antibody deficiency disorders, and other systemic conditions, please visit the companion website at eBooks.Health.Elsevier.com.

---

**JDR Centennial Series**

##### Periodontal Medicine: 100 Years of Progress
J.D. Beck, P.N. Papapanou, K.H. Philips, and S. Offenbacher

Journal of Dental Research
2019, Vol. 98(10) 1053–1062
© International &amp;amp; American Associations for Dental Research 2019
Article reuse guidelines: sagepub.com/journals-permissions
DOI: 10.1177/0022034519846113
journals.sagepub.com/home/jdr</formatted_text>
    <images>
      <img bbox="136,247,498,510" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="figure" path="L12 PerioDiabetes_figures/img_8ee3759f535dde89.webp">
        <description>Book cover image and metadata block for &amp;apos;Clinical Periodontology and Implant Dentistry, 2 Volume Set&amp;apos;. The visual includes the book cover on the left showing a dental professional in a purple coat, alongside details: authors (Niklaus P. Lang, Jan Lindhe), publisher (John Wiley &amp;amp; Sons, Incorporated), and date (2015-03-25).</description>
      </img>
      <img bbox="503,247,963,510" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="figure" path="L12 PerioDiabetes_figures/img_28fc506699a4e2b2.webp">
        <description>Chapter header graphic for &amp;apos;Influence of Systemic Conditions on the Periodontium&amp;apos; from Section V. The visual features a red banner with &amp;apos;SECTION V&amp;apos;, a beige strip with &amp;apos;CHAPTER 25&amp;apos;, the chapter title, author names (Perry R. Klokkevold et al.), and a note box directing readers to eBooks.Health.Elsevier.com for expanded discussions.</description>
      </img>
      <img bbox="500,583,963,708" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="figure" path="L12 PerioDiabetes_figures/img_840001ed316e23c6.webp">
        <description>Journal header graphic for &amp;apos;Periodontal Medicine: 100 Years of Progress&amp;apos; from JDR Centennial Series. Includes the JDR logo with a &amp;apos;100 YEARS&amp;apos; badge, article citation details (Vol. 98(10) 1053–1062), DOI, and a circular podcast icon labeled &amp;apos;PODCAST&amp;apos;.</description>
      </img>
    </images>
  </page>
  <page number="3">
    <text>```mermaid
graph TD
    subgraph Clinical_Health [Clinical Health]
        CH1[Health Promoting biofilm = Symbiosis]
        CH2[Low biomass]
        CH3[Proportionate Host response]
        CH4[Acute Resolution of inflammation]
        
        CH1 -- &amp;quot;Complement / PMNs&amp;quot; --&amp;gt; CH3
        CH2 -- &amp;quot;Antigens / Bact&amp;apos;l DNA / fMLP&amp;quot; --&amp;gt; CH4
    end

    subgraph Gingivitis [Gingivitis]
        G1[&amp;quot;Incipient Dysbiosis (Quorum Sensing Bacteria)&amp;quot;]
        G2[High biomass]
        G3[Proportionate Host response]
        G4[Chronic Resolution of inflammation]
        
        G1 -- &amp;quot;Antibody / PMNs ++ / T &amp;amp; B cells&amp;quot; --&amp;gt; G3
        G2 -- &amp;quot;Antigens / Virulence Factors / LPS&amp;quot; --&amp;gt; G4
    end

    subgraph Periodontitis [Periodontitis]
        P1[&amp;quot;Frank Dysbiosis (Pathogenic Biofilm)&amp;quot;]
        P2[High biomass]
        P3[&amp;quot;Disproportionate Host response (hyper-inflammatory)&amp;quot;]
        P4[Failed Resolution of inflammation]
        P5[&amp;quot;Connective Tissue &amp;amp; Bone Damage&amp;quot;]
        P6[Chronic non-Resolving inflammation]
        
        P1 -- &amp;quot;Antibody / PMNs +++ / Plasma cells&amp;quot; --&amp;gt; P3
        P2 -- &amp;quot;Antigens / Gingipains / LPS&amp;quot; --&amp;gt; P4
        P3 -- &amp;quot;DAMPs / Haem / GCF ↑&amp;quot; --&amp;gt; P5
        P4 -- &amp;quot;Cytokines / Prostanoids / MMPs / Oxidative Stress&amp;quot; --&amp;gt; P6
    end

    %% Risk Factors Arrows
    RF1[Behavioural risk factors absent] --&amp;gt;|Behavioural risk factors present| RF2[ ]
    RF3[Environmental risk factors absent] --&amp;gt;|Environmental risk factors evident| RF4[ ]
    RF5[Genetic risk factors absent] --&amp;gt;|Genetic risk factors present| RF6[ ]
    RF7[Epigenetic effects not evident] --&amp;gt;|Epigenetic effects evident| RF8[ ]
```

![Current etiopathogenesis model](L12 PerioDiabetes_figures/img_d8bd5571f80f4bef.webp)</text>
    <formatted_text>```mermaid
graph TD
    subgraph Clinical_Health [Clinical Health]
        CH1[Health Promoting biofilm = Symbiosis]
        CH2[Low biomass]
        CH3[Proportionate Host response]
        CH4[Acute Resolution of inflammation]

        CH1 -- &amp;quot;Complement / PMNs&amp;quot; --&amp;gt; CH3
        CH2 -- &amp;quot;Antigens / Bact&amp;apos;l DNA / fMLP&amp;quot; --&amp;gt; CH4
    end

    subgraph Gingivitis [Gingivitis]
        G1[&amp;quot;Incipient Dysbiosis (Quorum Sensing Bacteria)&amp;quot;]
        G2[High biomass]
        G3[Proportionate Host response]
        G4[Chronic Resolution of inflammation]

        G1 -- &amp;quot;Antibody / PMNs ++ / T &amp;amp; B cells&amp;quot; --&amp;gt; G3
        G2 -- &amp;quot;Antigens / Virulence Factors / LPS&amp;quot; --&amp;gt; G4
    end

    subgraph Periodontitis [Periodontitis]
        P1[&amp;quot;Frank Dysbiosis (Pathogenic Biofilm)&amp;quot;]
        P2[High biomass]
        P3[&amp;quot;Disproportionate Host response (hyper-inflammatory)&amp;quot;]
        P4[Failed Resolution of inflammation]
        P5[&amp;quot;Connective Tissue &amp;amp; Bone Damage&amp;quot;]
        P6[Chronic non-Resolving inflammation]

        P1 -- &amp;quot;Antibody / PMNs +++ / Plasma cells&amp;quot; --&amp;gt; P3
        P2 -- &amp;quot;Antigens / Gingipains / LPS&amp;quot; --&amp;gt; P4
        P3 -- &amp;quot;DAMPs / Haem / GCF ↑&amp;quot; --&amp;gt; P5
        P4 -- &amp;quot;Cytokines / Prostanoids / MMPs / Oxidative Stress&amp;quot; --&amp;gt; P6
    end

    %% Risk Factors Arrows
    RF1[Behavioural risk factors absent] --&amp;gt;|Behavioural risk factors present| RF2[ ]
    RF3[Environmental risk factors absent] --&amp;gt;|Environmental risk factors evident| RF4[ ]
    RF5[Genetic risk factors absent] --&amp;gt;|Genetic risk factors present| RF6[ ]
    RF7[Epigenetic effects not evident] --&amp;gt;|Epigenetic effects evident| RF8[ ]
```</formatted_text>
    <images>
      <img bbox="58,136,940,870" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="diagram" path="L12 PerioDiabetes_figures/img_d8bd5571f80f4bef.webp" caption="Current etiopathogenesis model">
        <description>A complex medical flowchart diagram illustrating the progression of oral health conditions from Clinical Health to Periodontitis. The diagram is organized into three main vertical columns: &amp;apos;Clinical Health&amp;apos; (green), &amp;apos;Gingivitis&amp;apos; (orange), and &amp;apos;Periodontitis&amp;apos; (red). 

Each column details a specific stage:
1. Clinical Health: Shows &amp;apos;Health Promoting biofilm = Symbiosis&amp;apos; and &amp;apos;Low biomass&amp;apos;. It indicates a &amp;apos;Proportionate Host response&amp;apos; leading to &amp;apos;Acute Resolution of inflammation&amp;apos;.
2. Gingivitis: Shows &amp;apos;Incipient Dysbiosis (Quorum Sensing Bacteria)&amp;apos; and &amp;apos;High biomass&amp;apos;. It indicates a &amp;apos;Proportionate Host response&amp;apos; but leads to &amp;apos;Chronic Resolution of inflammation&amp;apos;.
3. Periodontitis: Shows &amp;apos;Frank Dysbiosis (Pathogenic Biofilm)&amp;apos;, &amp;apos;High biomass&amp;apos;, and &amp;apos;Dis-proportionate Host response (hyper-inflammatory)&amp;apos;. This leads to &amp;apos;Failed Resolution of inflammation&amp;apos;, &amp;apos;Connective Tissue &amp;amp; Bone Damage&amp;apos;, and &amp;apos;Chronic non-Resolving inflammation&amp;apos;.

The diagram includes arrows indicating interactions between bacterial factors (Antigens, Virulence Factors, LPS, etc.) and host responses (Complement, PMNs, Antibody, Cytokines, etc.). Risk factors are noted at the top and bottom as absent or present for each condition.</description>
      </img>
    </images>
  </page>
  <page number="4">
    <text>**The UNIVERSITY OF**
**WESTERN**
**AUSTRALIA**

Although dental plaque accumulation is a cause of periodontal disease, it **may not be a sufficient** cause since some individuals have large accumulations of dental plaque and suffer little periodontal disease, while others have very little plaque accumulation and suffer severe periodontal disease. It appears then that **risk factors are important** in periodontal disease; determining **who develops the disease, the severity of the disease the individual develops, which sites in the dentition are affected, the rate of progression of the disease, the response to therapy, and the recurrence rate.** In assessing risk, the probability that a disease outcome will occur following a particular exposure is estimated (Last, 2001).

Risk factors (behavioural, environmental and genetic), have the potential to **modify** patient&amp;apos;s response to the presence of dental biofilm. This is important because periodontal tissue destruction in periodontitis fundamentally results from the body&amp;apos;s response to plaque rather that the plaque itself (Page and Schroeder, 1976).</text>
    <formatted_text>Although dental plaque accumulation is a cause of periodontal disease, it **may not be a sufficient** cause since some individuals have large accumulations of dental plaque and suffer little periodontal disease, while others have very little plaque accumulation and suffer severe periodontal disease. It appears then that **risk factors are important** in periodontal disease; determining **who develops the disease, the severity of the disease the individual develops, which sites in the dentition are affected, the rate of progression of the disease, the response to therapy, and the recurrence rate.** In assessing risk, the probability that a disease outcome will occur following a particular exposure is estimated (Last, 2001).

Risk factors (behavioural, environmental and genetic), have the potential to **modify** patient&amp;apos;s response to the presence of dental biofilm. This is important because periodontal tissue destruction in periodontitis fundamentally results from the body&amp;apos;s response to plaque rather than the plaque itself (Page and Schroeder, 1976).</formatted_text>
    <images>
      <img bbox="754,38,944,116" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="logo">
        <description>University of Western Australia institutional logo located in the top right corner. It features a blue shield with a white swan and three books above it, accompanied by the text &amp;apos;THE UNIVERSITY OF WESTERN AUSTRALIA&amp;apos;.</description>
      </img>
    </images>
  </page>
  <page number="5">
    <text>The University of Western Australia

**What is a risk factor?**

A risk factor can be an aspect of personal behaviour or life style, an environmental exposure, or an inborn or inherited characteristic that changes the susceptibility to periodontal disease. It can also be a local factor which increases the infection of a site.

**Types of risk factors for periodontal disease**

There are two major classes of risk factors for periodontal disease.

1. **Local factors** such as overhanging restorations and root caries that tend to allow for plaque accumulation and hence result in more periodontal disease. Other local risk factors for periodontal disease include pocket depth, intrabony pockets especially involving furcations, and root canal infections.

2. **Systemic factors** that affect the entire body, such as cigarette smoking, diabetes mellitus and genetic factors (Table 10.2).</text>
    <formatted_text>#### What is a risk factor?

A risk factor can be an aspect of personal behaviour or life style, an environmental exposure, or an inborn or inherited characteristic that changes the susceptibility to periodontal disease. It can also be a local factor which increases the infection of a site.

#### Types of risk factors for periodontal disease

There are two major classes of risk factors for periodontal disease.

1. **Local factors** such as overhanging restorations and root caries that tend to allow for plaque accumulation and hence result in more periodontal disease. Other local risk factors for periodontal disease include pocket depth, intrabony pockets especially involving furcations, and root canal infections.

2. **Systemic factors** that affect the entire body, such as cigarette smoking, diabetes mellitus and genetic factors (Table 10.2).</formatted_text>
    <images>
      <img bbox="750,39,946,118" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="logo">
        <description>University logo featuring a shield with a swan and books, alongside the text &amp;apos;THE UNIVERSITY OF WESTERN AUSTRALIA&amp;apos;.</description>
      </img>
    </images>
  </page>
  <page number="6">
    <text># Other used terms

## Predisposing Factors

Predisposing factors might increase the probability of disease occurrence and usually have localised effects.

These factors include anything, which retains or **hinders** the removal of dental plaque:

- dental calculus
- overhangs restorations,
- subgingival restorations,
- subgingival restoration margins,
- open contact points,
- partial dentures,
- tilted/rotated/crowded teeth,
- bulbous crowns,
- grooves on teeth and more.

## Modifying Factors

Modifying factors tend to act in a systemic fashion, which will alter the nature of a disease.

A modifying factor can alter the nature or course of the inflammatory response to the plaque by modifying:

- The susceptibility of disease,
- Plaque microbiota,
- Clinical presentation of periodontal disease,
- Disease progression and
- Response to treatment</text>
    <formatted_text>#### Predisposing Factors

Predisposing factors might increase the probability of disease occurrence and usually have localised effects.

These factors include anything which retains or **hinders** the removal of dental plaque:

- dental calculus
- overhangs restorations
- subgingival restorations
- subgingival restoration margins
- open contact points
- partial dentures
- tilted/rotated/crowded teeth
- bulbous crowns
- grooves on teeth and more.

#### Modifying Factors

Modifying factors tend to act in a systemic fashion, which will alter the nature of a disease.

A modifying factor can alter the nature or course of the inflammatory response to the plaque by modifying:

- The susceptibility of disease
- Plaque microbiota
- Clinical presentation of periodontal disease
- Disease progression
- Response to treatment</formatted_text>
    <images>
      <img bbox="801,39,935,124" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="logo">
        <description>University logo for The University of Western Australia featuring a shield with a swan and books.</description>
      </img>
    </images>
  </page>
  <page number="7">
    <text># SYSTEMIC MODIFYING FACTORS FOR PERIODONTAL DISEASE

**Diabetes**  
**Smoking**  
**Puberty**  
**Menopause**  
**Pregnancy**

### EFFECTS ON
* Physiological response
* Vascular system
* Inflammatory response
* Immune system
* Tissue repair
* Microbiota?

![](L12 PerioDiabetes_figures/img_a1ed1f6c15c3c4d4.webp)
![The CYPHER™ stent emits the drug Sirolimus inside an artery. This prevents reblockage of the artery.](L12 PerioDiabetes_figures/img_9629c3fd0d0ad3a1.webp)
![](L12 PerioDiabetes_figures/img_39ff3f537e0d8f0a.webp)
![Blood vessel damage in the feet may cause tissue damage](L12 PerioDiabetes_figures/img_8466c1db6c0b838b.webp)</text>
    <formatted_text>#### Systemic Modifying Factors for Periodontal Disease

- Diabetes
- Smoking
- Puberty
- Menopause
- Pregnancy

#### Effects on

- Physiological response
- Vascular system
- Inflammatory response
- Immune system
- Tissue repair
- Microbiota?</formatted_text>
    <images>
      <img bbox="506,347,718,559" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="figure" path="L12 PerioDiabetes_figures/img_a1ed1f6c15c3c4d4.webp">
        <description>Anatomical diagram of a heart showing internal chambers and valves. The image is illustrative in nature.</description>
      </img>
      <img bbox="731,347,943,559" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="figure" path="L12 PerioDiabetes_figures/img_9629c3fd0d0ad3a1.webp" caption="The CYPHER™ stent emits the drug Sirolimus inside an artery. This prevents reblockage of the artery.">
        <description>Illustration of a coronary artery with a stent inserted. The caption explains that the CYPHER™ stent releases Sirolimus to prevent reblockage.</description>
      </img>
      <img bbox="506,605,718,857" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="figure" path="L12 PerioDiabetes_figures/img_39ff3f537e0d8f0a.webp">
        <description>Diagram depicting immune cell activity. A large green cell (likely a macrophage) contains a grey &amp;apos;Infected Cell&amp;apos; and is interacting with other cellular elements, illustrating the inflammatory or immune response context.</description>
      </img>
      <img bbox="731,605,943,857" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="figure" path="L12 PerioDiabetes_figures/img_8466c1db6c0b838b.webp" caption="Blood vessel damage in the feet may cause tissue damage">
        <description>Comparative illustration of two feet labeled &amp;apos;Normal&amp;apos; and &amp;apos;Diabetic risk&amp;apos;. The diabetic foot shows visible vascular damage and tissue loss, demonstrating the systemic effects mentioned in the text.</description>
      </img>
    </images>
  </page>
  <page number="8">
    <text>**The University of Western Australia**

**Periodontal Medicine**

**Definition of periodontal medicine**

We view the term periodontal medicine, as first suggested by Offenbacher (7), to be a broad term that defines a rapidly emerging branch of periodontology focusing on the wealth of new data establishing a

Willians &amp;amp; Offenbacher 2000

strong relationship between periodontal health or disease and systemic health or disease. This means a two-way relationship in which periodontal disease in an individual may be a powerful influence on an individual&amp;apos;s systemic health or disease as well as the more customarily understood role that systemic disease may have in influencing an individual&amp;apos;s periodontal health or disease. Logically included in this definition would be new diagnostic and treatment strategies that recognize the relationship between periodontal disease and systemic disease.

![](L12 PerioDiabetes_figures/img_69f0e76f65ace0d2.webp)
![](L12 PerioDiabetes_figures/img_e408a2e1bc11c13f.webp)</text>
    <formatted_text>#### Definition of periodontal medicine

We view the term periodontal medicine, as first suggested by Offenbacher (7), to be a broad term that defines a rapidly emerging branch of periodontology focusing on the wealth of new data establishing a strong relationship between periodontal health or disease and systemic health or disease. This means a two-way relationship in which periodontal disease in an individual may be a powerful influence on an individual&amp;apos;s systemic health or disease as well as the more customarily understood role that systemic disease may have in influencing an individual&amp;apos;s periodontal health or disease. Logically included in this definition would be new diagnostic and treatment strategies that recognize the relationship between periodontal disease and systemic disease.

*Willians &amp;amp; Offenbacher 2000*</formatted_text>
    <images>
      <img bbox="89,215,364,466" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L12 PerioDiabetes_figures/img_69f0e76f65ace0d2.webp">
        <description>Clinical photo of a chattering teeth toy used to demonstrate periodontal disease (gum inflammation and tooth mobility).</description>
      </img>
      <img bbox="515,205,900,490" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="figure" path="L12 PerioDiabetes_figures/img_e408a2e1bc11c13f.webp">
        <description>Figure showing five anatomical models of the human body illustrating different systems: respiratory, skeletal, muscular, digestive, and circulatory. This visual supports the concept of systemic health relationships mentioned in the text.</description>
      </img>
    </images>
  </page>
  <page number="9">
    <text>**Periodontal Medicine**

SYSTEMIC DISEASES → PERIODONTITIS

More than a 100 systemic diseases/conditions and 500 medications have oral manifestations. Kane, 2017

SYSTEMIC DISEASES ← PERIODONTITIS

**EFP**  
European Federation of Periodontology  
DOSSIER ON  
PERIODONTAL DISEASE  

Periodontal Health for a Better Life  


![PERIODONTAL DISEASE CAN CAUSE TOOTH LOSS AND AFFECT THE REST OF THE BODY](L12 PerioDiabetes_figures/img_2aaae8f2587a845b.webp)</text>
    <formatted_text>**SYSTEMIC DISEASES → PERIODONTITIS**

More than a 100 systemic diseases/conditions and 500 medications have oral manifestations. *Kane, 2017*

**SYSTEMIC DISEASES ← PERIODONTITIS**

**EFP**
European Federation of Periodontology
DOSSIER ON PERIODONTAL DISEASE

Periodontal Health for a Better Life</formatted_text>
    <images>
      <img bbox="290,637,700,940" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="diagram" path="L12 PerioDiabetes_figures/img_2aaae8f2587a845b.webp" caption="PERIODONTAL DISEASE CAN CAUSE TOOTH LOSS AND AFFECT THE REST OF THE BODY">
        <description>A labelled diagram illustrating the systemic effects of periodontal disease. The image features a central vertical cross-section of a tooth and gingiva. An orange line extends from the gum tissue to various organ icons representing different body systems, including the heart, lungs, stomach/intestines, and joints, visually demonstrating that &amp;apos;Periodontal Disease can cause tooth loss and affect the rest of the body&amp;apos;. On the left side, there is a logo for the European Federation of Periodontology (EFP) with the text &amp;apos;DOSSIER ON PERIODONTAL DISEASE&amp;apos;. On the right, a circular inset provides a magnified view of the periodontal pocket area.</description>
      </img>
    </images>
  </page>
  <page number="10">
    <text># DIABETES
## The University of Western Australia

High level of blood glucose due to absolute or relative lack of hormone insulin

### **TYPE 1 DM**

*   Autoimmune destruction of pancreatic β-cells
*   Leads to total loss of insulin production
*   Usually diagnosed in children and adolescents

### **TYPE 2 DM**

*   Develop resistance to insulin with reduced β-cell function
*   Reduced insulin production, but retains ability for some insulin production
*   After 40 years old &amp;amp; associated with obesity

GESTATIONAL
(unspecified)

(Imagine the logo as if it were the text on the page)
The University of Western Australia</text>
    <formatted_text>High level of blood glucose due to absolute or relative lack of hormone insulin

#### Type 1 DM

- Autoimmune destruction of pancreatic β-cells
- Leads to total loss of insulin production
- Usually diagnosed in children and adolescents

#### Type 2 DM

- Develop resistance to insulin with reduced β-cell function
- Reduced insulin production, but retains ability for some insulin production
- After 40 years old &amp;amp; associated with obesity

#### Gestational

(unspecified)</formatted_text>
    <images>
      <img bbox="783,40,935,115" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="logo">
        <description>The official logo of The University of Western Australia, featuring a shield with a swan emblem and the university name in blue text.</description>
      </img>
    </images>
  </page>
  <page number="11">
    <text># PREVALENCE OF DIABETES

- Over 250 million worldwide (2007)
- Rates have doubled over past 20 years

www.worlddiabetesday.org  
**11**

![](L12 PerioDiabetes_figures/img_00a61d9a7131a1b8.webp)</text>
    <formatted_text>- Over 250 million worldwide (2007)
- Rates have doubled over past 20 years</formatted_text>
    <images>
      <img bbox="178,490,783,906" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="chart" path="L12 PerioDiabetes_figures/img_00a61d9a7131a1b8.webp">
        <description>Bar chart titled &amp;apos;PREVALENCE OF DIABETES&amp;apos; showing diabetes prevalence rates in various regions. The chart includes a legend indicating light blue bars represent the year 2000 and dark blue bars represent 2005. Regions shown include United States and Canada, Europe, Middle East, Sub-Saharan Africa, Latin America and the Caribbean, India, Southeast Asia, China, Australia, and others with corresponding percentage values.</description>
      </img>
    </images>
  </page>
  <page number="12">
    <text>- FATIGUE
- INFECTIONS
- VISION ALTERATION
- WEAKNESS
- HYPERGLYCEMIA
- PRURITUS (Itchy)
- POLYPHAGIA (xs eating)
- POLYURIA

&amp;lt;img&amp;gt;A diabetes awareness graphic showing symptoms including fatigue, infections, blurred vision, weight loss, slow-healing wounds, frequent urination, hunger, sexual problems, vaginal infections, and numbness. &amp;lt;img&amp;gt;

![DIABETES KNOW THE SYMPTOMS](L12 PerioDiabetes_figures/img_e3bc8dd0d2acfff2.webp)</text>
    <formatted_text>- FATIGUE
- INFECTIONS
- VISION ALTERATION
- WEAKNESS
- HYPERGLYCEMIA
- PRURITUS (Itchy)
- POLYPHAGIA (xs eating)
- POLYURIA</formatted_text>
    <images>
      <img bbox="470,219,895,883" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="figure" path="L12 PerioDiabetes_figures/img_e3bc8dd0d2acfff2.webp" caption="DIABETES KNOW THE SYMPTOMS">
        <description>Educational figure composed of a grid of nine panels illustrating clinical symptoms of diabetes. The main title &amp;apos;DIABETES&amp;apos; is prominent at the top with the subtitle &amp;apos;KNOW THE SYMPTOMS&amp;apos;. Panels depict: &amp;apos;Always tired&amp;apos; (fatigue), &amp;apos;Frequent urination&amp;apos; (polyuria), &amp;apos;Sudden weight loss&amp;apos;, &amp;apos;Wounds that won&amp;apos;t heal&amp;apos; (infections/weakness), &amp;apos;Always hungry&amp;apos; (polyphagia), &amp;apos;Sexual problems&amp;apos;, &amp;apos;Blurry vision&amp;apos; (vision alteration), &amp;apos;Vaginal infections&amp;apos; (infections/pruritus), and &amp;apos;Numb or tingling hands or feet&amp;apos; (neuropathy).</description>
      </img>
    </images>
  </page>
  <page number="13">
    <text>&amp;lt;br&amp;gt;
&amp;lt;br&amp;gt;
**PERIODONTAL ABSCCESS**
&amp;lt;br&amp;gt;

&amp;lt;br&amp;gt;
&amp;lt;br&amp;gt;
&amp;lt;br&amp;gt;

&amp;lt;br&amp;gt;
&amp;lt;br&amp;gt;
&amp;lt;br&amp;gt;
Diabetics are more susceptible to periodontal abcesses
(Ueta et al 1993)
&amp;lt;br&amp;gt;
&amp;lt;br&amp;gt;
13

![](L12 PerioDiabetes_figures/img_effbea263134086a.webp)</text>
    <formatted_text>**PERIODONTAL ABSCESS**

Diabetics are more susceptible to periodontal abscesses
(Ueta et al 1993)</formatted_text>
    <images>
      <img bbox="263,181,796,680" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L12 PerioDiabetes_figures/img_effbea263134086a.webp">
        <description>Clinical photograph showing an anterior view of upper teeth and gingiva. The image displays a periodontal abscess characterized by localized swelling (edema) on the attached gingiva above the lateral incisor/canine region. There is visible erythema and a small area of bleeding or ulceration associated with the abscess site.</description>
      </img>
    </images>
  </page>
  <page number="14">
    <text>**DIAGNOSIS &amp;amp; SCREENING**

**HbA1c (percent)**
**Fasting Plasma**
**Glucose**
**(mg/dL)**
**Oral Glucose**
**Tolerance Test**
**(mg/dL)**

| | HbA1c | Fasting Plasma Glucose | Oral Glucose Tolerance Test |
|---|---|---|---|
| **Diabetes** | ≥ 6.5 | ≥ 126 | ≥ 200 |
| **Prediabetes** | 5.7 – 6.4 | 100 - 125 | 140 – 199 |
| **Normal** | ~ 5.7 | ≤ 99 | ≤ 139 |

14

![](L12 PerioDiabetes_figures/img_c0447d0ce508006d.webp)</text>
    <formatted_text>**DIAGNOSIS &amp;amp; SCREENING**

| | HbA1c | Fasting Plasma Glucose (mg/dL) | Oral Glucose Tolerance Test (mg/dL) |
|---|---|---|---|
| **Diabetes** | ≥ 6.5 | ≥ 126 | ≥ 200 |
| **Prediabetes** | 5.7 – 6.4 | 100 - 125 | 140 – 199 |
| **Normal** | ~ 5.7 | ≤ 99 | ≤ 139 |</formatted_text>
    <images>
      <img bbox="135,190,640,520" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="table" path="L12 PerioDiabetes_figures/img_c0447d0ce508006d.webp">
        <description>A clinical table titled &amp;apos;DIAGNOSIS &amp;amp; SCREENING&amp;apos; showing diagnostic criteria for Diabetes, Prediabetes, and Normal ranges. The table has columns for HbA1c (percent), Fasting Plasma Glucose (mg/dL), and Oral Glucose Tolerance Test (mg/dL). Rows show: Diabetes (HbA1c ≥ 6.5, FPG ≥ 126, OGTT ≥ 200); Prediabetes (HbA1c 5.7–6.4, FPG 100–125, OGTT 140–199); Normal (~5.7, ≤99, ≤139).</description>
      </img>
    </images>
  </page>
  <page number="15">
    <text>&amp;lt;table style=&amp;quot;width:100%;text-align:left;font-family:Arial,sans-serif;font-size:14px;vertical-align:middle;&amp;quot;&amp;gt;
    &amp;lt;tr&amp;gt;
        &amp;lt;td colspan=&amp;quot;2&amp;quot;&amp;gt;&amp;lt;strong&amp;gt;HOW TO MEASURE GLYCEMIC CONTROL&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;
    &amp;lt;/tr&amp;gt;
    &amp;lt;tr&amp;gt;
        &amp;lt;td colspan=&amp;quot;2&amp;quot; style=&amp;quot;text-align:right;&amp;quot;&amp;gt;&amp;lt;a href=&amp;quot;#&amp;quot;&amp;gt;&amp;lt;img src=&amp;quot;https://upload.wikimedia.org/wikipedia/commons/thumb/c/c6/The_University_of_Western_Australia_coat_of_arms.svg/440px-The_University_of_Western_Australia_coat_of_arms.svg.png&amp;quot; width=&amp;quot;80&amp;quot; height=&amp;quot;42&amp;quot; style=&amp;quot;margin-bottom:5px;&amp;quot;&amp;gt;&amp;lt;/a&amp;gt;&amp;lt;/td&amp;gt;
    &amp;lt;/tr&amp;gt;
    &amp;lt;tr&amp;gt;
        &amp;lt;td colspan=&amp;quot;2&amp;quot; style=&amp;quot;height:10px;&amp;quot;&amp;gt;&amp;lt;/td&amp;gt;
    &amp;lt;/tr&amp;gt;
    &amp;lt;tr&amp;gt;
        &amp;lt;td colspan=&amp;quot;2&amp;quot; style=&amp;quot;height:10px;&amp;quot;&amp;gt;&amp;lt;/td&amp;gt;
    &amp;lt;/tr&amp;gt;
    &amp;lt;tr&amp;gt;
        &amp;lt;td colspan=&amp;quot;2&amp;quot; style=&amp;quot;height:10px;&amp;quot;&amp;gt;&amp;lt;/td&amp;gt;
    &amp;lt;/tr&amp;gt;
    &amp;lt;tr&amp;gt;
        &amp;lt;td colspan=&amp;quot;2&amp;quot; style=&amp;quot;height:10px;&amp;quot;&amp;gt;&amp;lt;/td&amp;gt;
    &amp;lt;/tr&amp;gt;
    &amp;lt;tr&amp;gt;
        &amp;lt;td colspan=&amp;quot;2&amp;quot; style=&amp;quot;height:10px;&amp;quot;&amp;gt;&amp;lt;/td&amp;gt;
    &amp;lt;/tr&amp;gt;
    &amp;lt;tr&amp;gt;
        &amp;lt;td colspan=&amp;quot;2&amp;quot; style=&amp;quot;height:10px;&amp;quot;&amp;gt;&amp;lt;/td&amp;gt;
    &amp;lt;/tr&amp;gt;
    &amp;lt;tr&amp;gt;
        &amp;lt;td colspan=&amp;quot;2&amp;quot; style=&amp;quot;height:15px;&amp;quot;&amp;gt;&amp;lt;/td&amp;gt;
    &amp;lt;/tr&amp;gt;
    &amp;lt;tr&amp;gt;
        &amp;lt;td colspan=&amp;quot;2&amp;quot;&amp;gt;&amp;lt;strong&amp;gt;GLYCOSYLATED HAEMOGLOBIN MOLECULE &amp;lt;br&amp;gt;(HbA1c)&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;
    &amp;lt;/tr&amp;gt;
    &amp;lt;tr&amp;gt;
        &amp;lt;td colspan=&amp;quot;2&amp;quot;&amp;gt;&amp;lt;strong&amp;gt;BINDING OF GLUCOSE TO HEMOGLOBIN&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;
    &amp;lt;/tr&amp;gt;
    &amp;lt;tr&amp;gt;
        &amp;lt;td colspan=&amp;quot;2&amp;quot;&amp;gt;&amp;lt;strong&amp;gt;% HbA1c INCREASES WITH HIGHER SERUM &amp;lt;br&amp;gt;GLUCOSE DURING LIFE OF RBC&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;
    &amp;lt;/tr&amp;gt;
    &amp;lt;tr&amp;gt;
        &amp;lt;td colspan=&amp;quot;2&amp;quot;&amp;gt;&amp;lt;strong&amp;gt;LIFE SPAN OF RBC – 100-120 DAYS&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;
    &amp;lt;/tr&amp;gt;
    &amp;lt;tr&amp;gt;
        &amp;lt;td colspan=&amp;quot;2&amp;quot;&amp;gt;&amp;lt;strong&amp;gt;New measurements at 3-4 months&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;
    &amp;lt;/tr&amp;gt;
    &amp;lt;tr&amp;gt;
        &amp;lt;td colspan=&amp;quot;2&amp;quot; style=&amp;quot;height:16px;&amp;quot;&amp;gt;&amp;lt;/td&amp;gt;
    &amp;lt;/tr&amp;gt;
    &amp;lt;tr&amp;gt;
        &amp;lt;td colspan=&amp;quot;2&amp;quot; style=&amp;quot;height:16px;&amp;quot;&amp;gt;&amp;lt;/td&amp;gt;
    &amp;lt;/tr&amp;gt;
    &amp;lt;tr&amp;gt;
        &amp;lt;td colspan=&amp;quot;2&amp;quot; style=&amp;quot;height:16px;&amp;quot;&amp;gt;&amp;lt;/td&amp;gt;
    &amp;lt;/tr&amp;gt;
    &amp;lt;tr&amp;gt;
        &amp;lt;td colspan=&amp;quot;2&amp;quot; style=&amp;quot;height:16px;&amp;quot;&amp;gt;&amp;lt;/td&amp;gt;
    &amp;lt;/tr&amp;gt;
    &amp;lt;tr&amp;gt;
        &amp;lt;td colspan=&amp;quot;2&amp;quot; style=&amp;quot;height:16px;&amp;quot;&amp;gt;&amp;lt;/td&amp;gt;
    &amp;lt;/tr&amp;gt;
    &amp;lt;tr&amp;gt;
        &amp;lt;td colspan=&amp;quot;2&amp;quot;&amp;gt;&amp;lt;strong&amp;gt;&amp;lt;span style=&amp;quot;font-weight:400; font-style:italic;&amp;quot;&amp;gt;15&amp;lt;/span&amp;gt;&amp;lt;/strong&amp;gt;&amp;lt;/td&amp;gt;
    &amp;lt;/tr&amp;gt;
&amp;lt;/table&amp;gt;

![](L12 PerioDiabetes_figures/img_964b838f2e0085b4.webp)</text>
    <formatted_text>**HOW TO MEASURE GLYCEMIC CONTROL**

**GLYCOSYLATED HAEMOGLOBIN MOLECULE (HbA1c)**

**BINDING OF GLUCOSE TO HEMOGLOBIN**

**% HbA1c INCREASES WITH HIGHER SERUM GLUCOSE DURING LIFE OF RBC**

**LIFE SPAN OF RBC – 100-120 DAYS**

**New measurements at 3-4 months**</formatted_text>
    <images>
      <img bbox="690,153,974,948" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="diagram" path="L12 PerioDiabetes_figures/img_964b838f2e0085b4.webp">
        <description>A vertical diagram illustrating A1c Test Results. It features a central column with three colored targets (red at the top, yellow in the middle, green at the bottom) connected by arrows pointing upwards and downwards. Each target is labeled with a category and percentage range: &amp;apos;Diabetes 6.5% or higher&amp;apos; (red), &amp;apos;Prediabetes 5.7 to 6.4%&amp;apos; (yellow), and &amp;apos;Normal Below 5.7%&amp;apos; (green). The diagram visually represents the scale of glycemic control.</description>
      </img>
    </images>
  </page>
  <page number="16">
    <text>&amp;lt;b&amp;gt;COMPLICATIONS AND TREATMENT&amp;lt;/b&amp;gt;

&amp;lt;b&amp;gt;PERIODONTAL DISEASE&amp;lt;/b&amp;gt; has been called the 6th complication of diabetes  
(Löe 1993)

Tratamento  
• Redução das taxas de glicose a fim de prevenir sinais/sintomas e complicações  
– Controle glicêmico - manutenção de níveis controlados a fim de prevenir complicações

16

![](L12 PerioDiabetes_figures/img_bc42873e5c3569fb.webp)</text>
    <formatted_text>**COMPLICATIONS AND TREATMENT**

**PERIODONTAL DISEASE** has been called the 6th complication of diabetes
(Löe 1993)

**Treatment**

- Redução das taxas de glicose a fim de prevenir sinais/sintomas e complicações
  – Controle glicêmico - manutenção de níveis controlados a fim de prevenir complicações</formatted_text>
    <images>
      <img bbox="216,154,783,702" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="diagram" path="L12 PerioDiabetes_figures/img_bc42873e5c3569fb.webp">
        <description>Medical diagram titled &amp;apos;Diabetes&amp;apos; and &amp;apos;Complications of Chronic Hyperglycemia&amp;apos;. It features a central illustration of the human body with highlighted vascular systems. Yellow callout boxes point to specific regions: &amp;apos;Retinopathy&amp;apos; (pointing to the head/eye area), &amp;apos;Stroke&amp;apos;, &amp;apos;Heart disease&amp;apos; (pointing to the chest), &amp;apos;Nephropathy&amp;apos; (pointing to the kidneys), &amp;apos;Peripheral neuropathy&amp;apos; (pointing to the legs), and &amp;apos;Autonomic neuropathy&amp;apos; (pointing to the torso). Each box lists associated symptoms or conditions.</description>
      </img>
    </images>
  </page>
  <page number="17">
    <text># RELATIONSHIP BETWEEN DIABETES &amp;amp; PERIODONTAL DISEASE

17

![](L12 PerioDiabetes_figures/img_497ff1c2d57d2462.webp)</text>
    <images>
      <img bbox="835,461,970,636" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L12 PerioDiabetes_figures/img_497ff1c2d57d2462.webp">
        <description>Clinical photo showing inflamed gingival tissue with erythema and edema surrounding the cervical areas of multiple teeth. A tooth is marked with an asterisk (*), indicating a specific site of interest or pathology related to periodontal disease.</description>
      </img>
    </images>
  </page>
  <page number="18">
    <text># RELATIONSHIP BETWEEN DIABETES &amp;amp; PERIODONTAL DISEASE
**The University of Western Australia**

*   Approximately **40%** of adult Pima Indians in Arizona have type 2 diabetes.
*   A comparison of individuals with and without diabetes in this Native American tribe showed a clear increase in the prevalence of destructive periodontitis as well as a **15%** increase in edentulousness among patients with diabetes

18

![](L12 PerioDiabetes_figures/img_47621ebd1d637cf0.webp)
![](L12 PerioDiabetes_figures/img_44d7f690d5a3bd49.webp)</text>
    <formatted_text>- Approximately **40%** of adult Pima Indians in Arizona have type 2 diabetes.
- A comparison of individuals with and without diabetes in this Native American tribe showed a clear increase in the prevalence of destructive periodontitis as well as a **15%** increase in edentulousness among patients with diabetes.</formatted_text>
    <images>
      <img bbox="117,516,440,950" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L12 PerioDiabetes_figures/img_47621ebd1d637cf0.webp">
        <description>Black and white historical photo showing two Pima Indians in Arizona. One is seated on a large rock by a riverbank, while the other stands nearby. The image illustrates the demographic group discussed in the text regarding diabetes prevalence.</description>
      </img>
      <img bbox="468,639,845,943" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L12 PerioDiabetes_figures/img_44d7f690d5a3bd49.webp">
        <description>Black and white historical photo showing a person sitting in front of a traditional thatched dwelling or hut. This visual provides context for the lifestyle and environment of the Native American tribe mentioned in the study.</description>
      </img>
    </images>
  </page>
  <page number="19">
    <text># RELATIONSHIP BETWEEN DIABETES &amp;amp; PERIODONTAL DISEASE

*   Periodontitis&amp;apos; prevalence is increased in diabetics

*   **2.8-3.4**X increase in risk for periodontitis

*   Poorly controlled (type 2 DM) had **X11** increased risk for periodontitis compared to non-diabetic

*   Glycemic control is related to periodontitis in a dose-response manner (the level of hyperglycemia is related to periodontitis)

*   Diabetics with complications have poorer periodontal conditions

*   Well controlled diabetics had similar risk for periodontitis to non-diabetics

![](L12 PerioDiabetes_figures/img_f92efeedc5184489.webp)
![](L12 PerioDiabetes_figures/img_977456d219d17af3.webp)</text>
    <formatted_text>- Periodontitis&amp;apos; prevalence is increased in diabetics.
- **2.8-3.4**X increase in risk for periodontitis.
- Poorly controlled (type 2 DM) had **X11** increased risk for periodontitis compared to non-diabetic.
- Glycemic control is related to periodontitis in a dose-response manner (the level of hyperglycemia is related to periodontitis).
- Diabetics with complications have poorer periodontal conditions.
- Well controlled diabetics had similar risk for periodontitis to non-diabetics.</formatted_text>
    <images>
      <img bbox="662,290,950,460" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="figure" path="L12 PerioDiabetes_figures/img_f92efeedc5184489.webp">
        <description>Graphic illustration showing an &amp;apos;X11&amp;apos; multiplier symbol with explosive effects, visually representing the 11-fold increased risk for periodontitis in poorly controlled Type 2 diabetics mentioned in the adjacent text.</description>
      </img>
      <img bbox="600,472,950,875" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L12 PerioDiabetes_figures/img_977456d219d17af3.webp">
        <description>Clinical photograph of a human mouth displaying severe periodontitis, characterized by inflamed red gingiva and visible calculus deposits on the teeth.</description>
      </img>
    </images>
  </page>
  <page number="20">
    <text>- Degree of glycemic/metabolic control  
- Age  
- Duration of DM  
- Severity of DM - Complications

![](L12 PerioDiabetes_figures/img_17d28f36e3447844.webp)
![](L12 PerioDiabetes_figures/img_5662d32436990624.webp)
![](L12 PerioDiabetes_figures/img_da43f851c817cf8a.webp)
![](L12 PerioDiabetes_figures/img_48e367f50ab9c83e.webp)</text>
    <formatted_text>- Degree of glycemic/metabolic control
- Age
- Duration of DM
- Severity of DM - Complications</formatted_text>
    <images>
      <img bbox="35,108,964,188" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="diagram" path="L12 PerioDiabetes_figures/img_17d28f36e3447844.webp">
        <description>A conceptual flow diagram illustrating the relationship between two conditions. On the left is a green rectangular box labeled &amp;apos;Diabetes&amp;apos;, and on the right is a blue rectangular box labeled &amp;apos;Periodontitis&amp;apos;. A large orange arrow points from the Diabetes box to the Periodontitis box, indicating a causal link or progression.</description>
      </img>
      <img bbox="35,176,964,412" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="figure" path="L12 PerioDiabetes_figures/img_5662d32436990624.webp">
        <description>A text-based list of risk factors associated with the condition shown in the diagram above. The list includes: Degree of glycemic/metabolic control, Age, Duration of DM, and Severity of DM - Complications.</description>
      </img>
      <img bbox="35,606,480,974" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L12 PerioDiabetes_figures/img_da43f851c817cf8a.webp">
        <description>A clinical photograph showing a close-up view of teeth with significant periodontal disease. The gingiva appears red, swollen, and inflamed, particularly at the gum line. There is visible recession exposing the tooth roots and darkened pockets between the teeth, consistent with severe periodontitis.</description>
      </img>
      <img bbox="515,606,964,974" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L12 PerioDiabetes_figures/img_48e367f50ab9c83e.webp">
        <description>A second clinical photograph, positioned next to the first one, also depicting severe periodontitis. It shows similar signs of inflammation, redness, and gingival recession around the teeth, providing visual evidence of the condition discussed in the slide.</description>
      </img>
    </images>
  </page>
  <page number="21">
    <text># WHY ARE DIABETICS MORE SUSCEPTIBLE TO PERIODONTAL DISEASE?

21</text>
    <images>
      <img bbox="850,36,948,106" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="logo">
        <description>University logo for The University of Western Australia, featuring a shield with a swan and text.</description>
      </img>
    </images>
  </page>
  <page number="22">
    <text># DO DIABETICS HAVE DIFFERENT BACTERIA?

*   Earlier studies in 1980s &amp;amp; 1990s (using culture) found higher levels of **SPIROCHETES** &amp;amp; **MOTILE RODS** in diabetics (vs healthy controls)
*   More recent studies (using molecular techniques such as PCR) found similar levels of putative periodontal pathogens between diabetics &amp;amp; non-diabetics
*   **CONCLUDE: increase in susceptibility to periodontal disease in diabetics is NOT due to differences in composition of the microbiota**

![](L12 PerioDiabetes_figures/img_c714c13c51372a1e.webp)</text>
    <formatted_text>- Earlier studies in 1980s &amp;amp; 1990s (using culture) found higher levels of **SPIROCHETES** &amp;amp; **MOTILE RODS** in diabetics (vs healthy controls).
- More recent studies (using molecular techniques such as PCR) found similar levels of putative periodontal pathogens between diabetics &amp;amp; non-diabetics.
- **CONCLUDE: increase in susceptibility to periodontal disease in diabetics is NOT due to differences in composition of the microbiota.**</formatted_text>
    <images>
      <img bbox="665,312,966,738" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L12 PerioDiabetes_figures/img_c714c13c51372a1e.webp">
        <description>A circular microscopic image showing several green-stained rod-shaped bacteria (bacteroids), illustrating the subject of periodontal pathogens mentioned in the text.</description>
      </img>
    </images>
  </page>
  <page number="23">
    <text>**HOST RESPONSE IN DIABETICS**

Impaired neutrophil function:
• Impaired neutrophil adherence, chemotaxis &amp;amp; phagocytosis
(produce less oxygen radicals)
• **Bacteria persists in periodontal pocket**

&amp;lt;p align=&amp;quot;right&amp;quot;&amp;gt;23&amp;lt;/p&amp;gt;</text>
    <formatted_text>**Impaired neutrophil function:**
- Impaired neutrophil adherence, chemotaxis &amp;amp; phagocytosis (produce less oxygen radicals).
- **Bacteria persists in periodontal pocket.**</formatted_text>
  </page>
  <page number="24">
    <text>Polymorphonuclear Leukocyte Function

**The increased susceptibility of patients with diabetes to infection has been hypothesized as being caused by polymorphonuclear leukocyte (PMN) deficiencies that result in impaired chemotaxis, defective phagocytosis, or impaired adherence.** In patients with poorly controlled diabetes, the functions of PMNs, monocytes, and **macrophages** are impaired. As a result, the primary defense mounted by PMNs against periodontal pathogens is diminished, and bacterial proliferation is more likely. No alteration of **immunoglobulin A (IgA)**, G (IgG), or M (IgM) has been found in patients with diabetes.</text>
    <formatted_text>**Polymorphonuclear Leukocyte Function**

The increased susceptibility of patients with diabetes to infection has been hypothesized as being caused by polymorphonuclear leukocyte (PMN) deficiencies that result in impaired chemotaxis, defective phagocytosis, or impaired adherence. In patients with poorly controlled diabetes, the functions of PMNs, monocytes, and **macrophages** are impaired. As a result, the primary defense mounted by PMNs against periodontal pathogens is diminished, and bacterial proliferation is more likely. No alteration of **immunoglobulin A (IgA)**, G (IgG), or M (IgM) has been found in patients with diabetes.</formatted_text>
    <images>
      <img bbox="764,30,952,117" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="logo">
        <description>University logo for The University of Western Australia.</description>
      </img>
    </images>
  </page>
  <page number="25">
    <text>- Impaired immune response in periodontium of diabetics suggested in 1960s
- Structural changes: with sustained hyperglycemia, proteins become **irreversibly glycated** to form **advanced glycation end products (AGEs)**
- Formation of AGEs also occurs in the periodontium
- Higher levels found in diabetic patients
- AGEs activate a receptor known as &amp;quot;**receptor for AGEs**&amp;quot; (RAGE) found on the surface of smooth muscle cells, endothelial cells &amp;amp; monocytes/macrophages &amp;amp; gingival tissues of type 2 diabetics
- Hyperglycemia results in increased RAGE expression

(Frantzis et al. 1971; Schmidt et al. 1996; 1999)</text>
    <formatted_text>- Impaired immune response in periodontium of diabetics suggested in 1960s.
- Structural changes: with sustained hyperglycemia, proteins become **irreversibly glycated** to form **advanced glycation end products (AGEs)**.
- Formation of AGEs also occurs in the periodontium.
- Higher levels found in diabetic patients.
- AGEs activate a receptor known as &amp;quot;**receptor for AGEs**&amp;quot; (RAGE) found on the surface of smooth muscle cells, endothelial cells &amp;amp; monocytes/macrophages &amp;amp; gingival tissues of type 2 diabetics.
- Hyperglycemia results in increased RAGE expression.

(Frantzis et al. 1971; Schmidt et al. 1996; 1999)</formatted_text>
    <images>
      <img bbox="837,45,961,108" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="logo">
        <description>The University of Western Australia logo featuring a shield with a swan and text.</description>
      </img>
    </images>
  </page>
  <page number="26">
    <text>**Altered Collagen Metabolism**

Chronic hyperglycemia **impairs** *collagen* structure and function, which may directly impact the integrity of the periodontium. **Decreased** collagen synthesis, osteoporosis, and a **reduction** in alveolar bone height have been demonstrated in diabetic animals. 97, 233</text>
    <formatted_text>**Altered Collagen Metabolism**

Chronic hyperglycemia **impairs** *collagen* structure and function, which may directly impact the integrity of the periodontium. **Decreased** collagen synthesis, osteoporosis, and a **reduction** in alveolar bone height have been demonstrated in diabetic animals. 97, 233</formatted_text>
    <images>
      <img bbox="756,40,936,121" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="logo">
        <description>University logo for The University of Western Australia located in the top right corner.</description>
      </img>
    </images>
  </page>
  <page number="27">
    <text>Chronic hyperglycemia **adversely affects** the synthesis, maturation, and maintenance of collagen and extracellular matrix. In the hyper-glycemic state, numerous proteins and matrix molecules undergo a nonenzymatic glycosylation, thereby resulting in *advanced gly-compression end-products (AGEs)*. The formation of AGEs occurs at normal glucose levels as well; however, in hyperglycemic environments, AGE formation is excessive. Many types of molecules are affected, including proteins, lipids, and carbohydrates. Collagen is cross-linked by AGE formation, which makes the collagen less soluble and less likely to be normally repaired or replaced. Cellular migration through cross-linked collagen is impeded, and, perhaps more importantly, tissue integrity is impaired as a result of damaged collagen that remains in the tissues for longer periods (i.e., collagen is not renewed at a normal rate).$^{113}$ As a result, collagen in the tissues of patients with poorly controlled diabetes is older and more susceptible to pathogenic breakdown (i.e., less resistant to destruction by periodontal infections).</text>
    <formatted_text>Chronic hyperglycemia **adversely affects** the synthesis, maturation, and maintenance of collagen and extracellular matrix. In the hyper-glycemic state, numerous proteins and matrix molecules undergo a nonenzymatic glycosylation, thereby resulting in *advanced gly-compression end-products (AGEs)*. The formation of AGEs occurs at normal glucose levels as well; however, in hyperglycemic environments, AGE formation is excessive. Many types of molecules are affected, including proteins, lipids, and carbohydrates. Collagen is cross-linked by AGE formation, which makes the collagen less soluble and less likely to be normally repaired or replaced. Cellular migration through cross-linked collagen is impeded, and, perhaps more importantly, tissue integrity is impaired as a result of damaged collagen that remains in the tissues for longer periods (i.e., collagen is not renewed at a normal rate).$^{113}$ As a result, collagen in the tissues of patients with poorly controlled diabetes is older and more susceptible to pathogenic breakdown (i.e., less resistant to destruction by periodontal infections).</formatted_text>
  </page>
  <page number="28">
    <text>AGEs and receptors for AGEs (RAGEs) play a central role in the classic complications of diabetes,$^{36}$ and they may play a significant role in the progression of periodontal disease as well. Poor glycemic control, with the associated increase in AGEs, renders the periodontal tissues more susceptible to destruction.$^{232}$ The cumulative effects of altered cellular response to local factors, impaired tissue integrity, and altered collagen metabolism undoubtedly play a significant role in the susceptibility of patients with diabetes to infections and destructive periodontal disease.</text>
    <formatted_text>AGEs and receptors for AGEs (RAGEs) play a central role in the classic complications of diabetes,$^{36}$ and they may play a significant role in the progression of periodontal disease as well. Poor glycemic control, with the associated increase in AGEs, renders the periodontal tissues more susceptible to destruction.$^{232}$ The cumulative effects of altered cellular response to local factors, impaired tissue integrity, and altered collagen metabolism undoubtedly play a significant role in the susceptibility of patients with diabetes to infections and destructive periodontal disease.</formatted_text>
    <images>
      <img bbox="796,38,971,114" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="logo">
        <description>The logo for The University of Western Australia, featuring a blue shield with a swan and open books.</description>
      </img>
    </images>
  </page>
  <page number="29">
    <text>**Stimulates monocytes &amp;amp; macrophages to proliferate,**
**upregulate pro-inflammatory cytokines such as IL-1β,**
**PgE2 and TNF-α &amp;amp; produce free O2 radicals**

These free O2 radicals &amp;amp; pro-inflammatory cytokines contribute to the pathogenesis of periodontal disease

Direct cell/host damage

(Schmidt et al. 1996; 1999; Engebretson et al. 2004; Katz et al. 2005)
29</text>
    <formatted_text>**Stimulates monocytes &amp;amp; macrophages to proliferate, upregulate pro-inflammatory cytokines such as IL-1β, PgE2 and TNF-α &amp;amp; produce free O2 radicals**

These free O2 radicals &amp;amp; pro-inflammatory cytokines contribute to the pathogenesis of periodontal disease.

Direct cell/host damage.

(Schmidt et al. 1996; 1999; Engebretson et al. 2004; Katz et al. 2005)</formatted_text>
    <images>
      <img bbox="856,39,1000,108" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="logo">
        <description>The University of Western Australia institutional logo featuring a shield with a swan and open books.</description>
      </img>
    </images>
  </page>
  <page number="30">
    <text>**HOST RESPONSE IN DIABETICS**

Higher levels of inflammatory cytokines &amp;amp; mediators found in GCF of diabetics

Monocytes &amp;amp; macrophages with a destructive phenotype

![](L12 PerioDiabetes_figures/img_12d7645173b2b27e.webp)</text>
    <formatted_text>Higher levels of inflammatory cytokines &amp;amp; mediators found in GCF of diabetics.

Monocytes &amp;amp; macrophages with a destructive phenotype.</formatted_text>
    <images>
      <img bbox="782,530,965,912" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L12 PerioDiabetes_figures/img_12d7645173b2b27e.webp">
        <description>Microscopic image showing a large, textured red cell (likely a macrophage) surrounded by smaller green rod-shaped bacteria, illustrating the interaction between host cells and pathogens.</description>
      </img>
    </images>
  </page>
  <page number="31">
    <text>![FIGURE 2 Conceptual model connecting diabetes with periodontitis, and showing possible pathogenic factors and risk factors. AGEs, advanced glycation end-products; IL, interleukin; LPS, lipopolysaccharides; ROS, reactive oxygen species; TNF-α, tumor necrosis factor-alpha](L12 PerioDiabetes_figures/img_7d78e1336d424124.webp)</text>
    <images>
      <img bbox="147,83,569,805" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="diagram" path="L12 PerioDiabetes_figures/img_7d78e1336d424124.webp" caption="FIGURE 2 Conceptual model connecting diabetes with periodontitis, and showing possible pathogenic factors and risk factors. AGEs, advanced glycation end-products; IL, interleukin; LPS, lipopolysaccharides; ROS, reactive oxygen species; TNF-α, tumor necrosis factor-alpha">
        <description>Labelled conceptual diagram illustrating the bidirectional relationship between Diabetes mellitus and Periodontitis. The diagram is organized into two main pathways originating from &amp;apos;Diabetes mellitus&amp;apos; (top) and converging on &amp;apos;Periodontitis&amp;apos; (bottom). 

The left pathway details the effects of Insulin resistance leading to inflammatory cytokines (IL-1, IL-6, TNF-α), which are influenced by Bacterial Factors (LPS).

The right pathway shows Hyperglycemia leading to oxidative stress markers (ROS, AGEs) and systemic inflammation, resulting in an Exaggerated Immune response and Glycation.

A central box labeled &amp;apos;Common risks&amp;apos; lists shared contributors: Obesity, age, sex, genetic, smoking, and socio economic factors. Arrows indicate feedback loops and causal relationships between these nodes.</description>
      </img>
    </images>
  </page>
  <page number="32">
    <text>**HEALING RESPONSE**  
THE UNIVERSITY OF WESTERN AUSTRALIA  

In a hyperglycemic state, repair process in periodontium is compromised due to:  
- Gingival fibroblasts produce less collagen &amp;amp; more MMPs  
- Recently synthesized collagen is rapidly degraded by elevated levels of active MMPs  
- Decreased osteoblast proliferation &amp;amp; collagen production  
- Increased rate of apoptosis of fibroblasts &amp;amp; osteoblasts  

(Loder 1988; Inaba et al. 1999; Lu et al. 2003; Gooch et al. 2000; He et al. 2004; Liu et al. 2004)  
32</text>
    <formatted_text>**HEALING RESPONSE**

In a hyperglycemic state, repair process in periodontium is compromised due to:
- Gingival fibroblasts produce less collagen &amp;amp; more MMPs.
- Recently synthesized collagen is rapidly degraded by elevated levels of active MMPs.
- Decreased osteoblast proliferation &amp;amp; collagen production.
- Increased rate of apoptosis of fibroblasts &amp;amp; osteoblasts.

(Loder 1988; Inaba et al. 1999; Lu et al. 2003; Gooch et al. 2000; He et al. 2004; Liu et al. 2004)</formatted_text>
    <images>
      <img bbox="765,39,940,118" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="logo">
        <description>University logo for The University of Western Australia.</description>
      </img>
    </images>
  </page>
  <page number="33">
    <text># HEALING RESPONSE

33

![](L12 PerioDiabetes_figures/img_7c7772df7a5f9808.webp)
![](L12 PerioDiabetes_figures/img_746f7a92f0950bba.webp)</text>
    <images>
      <img bbox="123,316,539,842" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L12 PerioDiabetes_figures/img_7c7772df7a5f9808.webp">
        <description>Clinical photo showing a wound on the sole and heel of a foot with a scale bar attached.</description>
      </img>
      <img bbox="609,316,952,606" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L12 PerioDiabetes_figures/img_746f7a92f0950bba.webp">
        <description>Clinical photo showing a large wound on a leg with a scale bar attached.</description>
      </img>
    </images>
  </page>
  <page number="34">
    <text># HOST RESPONSE IN DIABETICS

**Together, the impaired immune response, poorer healing &amp;amp; increased destruction may explain the greater propensity of diabetics to have more severe periodontal disease** 

(Loder 1988; Inaba et al. 1999; Lu et al. 2003; Gooch et al. 2000; He et al. 2004; Liu et al. 2004) 

34

![](L12 PerioDiabetes_figures/img_b0216e43c50c5b03.webp)</text>
    <formatted_text>Together, the impaired immune response, poorer healing &amp;amp; increased destruction may explain the greater propensity of diabetics to have more severe periodontal disease.

(Loder 1988; Inaba et al. 1999; Lu et al. 2003; Gooch et al. 2000; He et al. 2004; Liu et al. 2004)</formatted_text>
    <images>
      <img bbox="309,274,681,735" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="figure" path="L12 PerioDiabetes_figures/img_b0216e43c50c5b03.webp">
        <description>A cartoon illustration featuring a green anthropomorphic hand with glasses and a tie in the foreground. A speech bubble from the hand contains text reading &amp;apos;don&amp;apos;t let AGE RAGE claim you! watch for the signs&amp;apos;. In the background, a pink cat-like character wearing a party hat sits on an office chair.</description>
      </img>
    </images>
  </page>
  <page number="35">
    <text>INFLUENCE OF **PERIODONTAL DISEASE** ON **DIABETES**

---

**35**

![](L12 PerioDiabetes_figures/img_d211736f9bf035de.webp)</text>
    <formatted_text>**Influence of Periodontal Disease on Diabetes**</formatted_text>
    <images>
      <img bbox="571,430,965,830" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L12 PerioDiabetes_figures/img_d211736f9bf035de.webp">
        <description>Clinical photograph of a patient&amp;apos;s anterior dentition demonstrating severe periodontal disease. The image shows significant gingival inflammation (redness), recession exposing root surfaces, and heavy accumulation of supra- and subgingival calculus (tartar) on the teeth.</description>
      </img>
    </images>
  </page>
  <page number="36">
    <text>The University of Western Australia
INFLUENCE OF PERIODONTAL DISEASE ON DIABETES

**Proposed mechanism:** periodontal infection may add to systemic inflammation which induces insulin resistance
**High levels of cytokines** can affect efficacy of insulin receptor

Insulin
Glucose

Insulin receptors

Glut-4

Defect in signaling to Glut-4

Diamond muscle cells

Glucose transporters

Diminished glucose uptake

36

![](L12 PerioDiabetes_figures/img_0bafe5ffcf86ba0f.webp)
![Type 2 Diabetes: Insulin Resistance](L12 PerioDiabetes_figures/img_0633fcc01c2d1c18.webp)</text>
    <formatted_text>**Proposed mechanism:** periodontal infection may add to systemic inflammation which induces insulin resistance

**High levels of cytokines** can affect efficacy of insulin receptor

- Insulin
- Glucose
- Insulin receptors
- Glut-4
- Defect in signaling to Glut-4
- Diamond muscle cells
- Glucose transporters
- Diminished glucose uptake</formatted_text>
    <images>
      <img bbox="153,608,415,947" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L12 PerioDiabetes_figures/img_0bafe5ffcf86ba0f.webp">
        <description>Clinical photograph of a tooth exhibiting severe periodontal disease. The image shows the gum line receding significantly below the crown of the tooth, exposing the root surface. There appears to be inflammation (redness) in the surrounding tissue and potential calculus or plaque accumulation near the base of the tooth.</description>
      </img>
      <img bbox="502,482,967,947" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="diagram" path="L12 PerioDiabetes_figures/img_0633fcc01c2d1c18.webp" caption="Type 2 Diabetes: Insulin Resistance">
        <description>Biological diagram illustrating the mechanism of insulin resistance in Type 2 diabetes within muscle cells. The diagram depicts &amp;apos;Insulin&amp;apos; molecules interacting with &amp;apos;Insulin receptors&amp;apos;. A red &amp;apos;X&amp;apos; indicates a &amp;apos;Defect in signaling to Glut-4&amp;apos;, preventing the activation of &amp;apos;Glucose transporters&amp;apos;. This results in &amp;apos;Diminished glucose uptake&amp;apos; by the cell from the surrounding environment containing &amp;apos;Glucose&amp;apos;.</description>
      </img>
    </images>
  </page>
  <page number="37">
    <text>Periodontitis Modified by Systemic Factors
**Diabetes Mellitus**

The University of Western Australia

**eFig. 7.109** Severe gingival inflammation and periodontal abscess occurred in a 26-year-old woman with type 1 **diabetes mellitus**. Notice the extrusion of the maxillary left central incisor caused by alveolar bone loss.

**eFig. 7.110** Severe inflammation, pus formation, and periodontal breakdown occurred in a 34-year-old man with uncontrolled type 1 **diabetes mellitus**.

![eFig. 7.109 Severe gingival inflammation and periodontal abscess occurred in a 26-year-old woman with type 1 diabetes mellitus. Notice the extrusion of the maxillary left central incisor caused by alveolar bone loss.](L12 PerioDiabetes_figures/img_198eab1900bf69a7.webp)
![eFig. 7.110 Severe inflammation, pus formation, and periodontal breakdown occurred in a 34-year-old man with uncontrolled type 1 diabetes mellitus.](L12 PerioDiabetes_figures/img_4af94aecc9a8efc3.webp)</text>
    <formatted_text>#### Periodontitis Modified by Systemic Factors: Diabetes Mellitus

**eFig. 7.109** Severe gingival inflammation and periodontal abscess occurred in a 26-year-old woman with type 1 **diabetes mellitus**. Notice the extrusion of the maxillary left central incisor caused by alveolar bone loss.

**eFig. 7.110** Severe inflammation, pus formation, and periodontal breakdown occurred in a 34-year-old man with uncontrolled type 1 **diabetes mellitus**.</formatted_text>
    <images>
      <img bbox="220,148,582,455" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L12 PerioDiabetes_figures/img_198eab1900bf69a7.webp" caption="eFig. 7.109 Severe gingival inflammation and periodontal abscess occurred in a 26-year-old woman with type 1 diabetes mellitus. Notice the extrusion of the maxillary left central incisor caused by alveolar bone loss.">
        <description>Clinical photo showing severe gingival inflammation and a periodontal abscess on the upper front teeth of a patient with type 1 diabetes. The caption notes the extrusion of the maxillary left central incisor due to bone loss.</description>
      </img>
      <img bbox="220,578,582,895" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L12 PerioDiabetes_figures/img_4af94aecc9a8efc3.webp" caption="eFig. 7.110 Severe inflammation, pus formation, and periodontal breakdown occurred in a 34-year-old man with uncontrolled type 1 diabetes mellitus.">
        <description>Clinical photo showing severe inflammation, pus formation, and periodontal breakdown in the mouth of a 34-year-old man with uncontrolled type 1 diabetes mellitus.</description>
      </img>
    </images>
  </page>
  <page number="38">
    <text>

**THE UNIVERSITY OF WESTERN AUSTRALIA**

**eFig. 7.111** Two views show the dentition of a 14-year-old girl who was referred with a complaint of tooth mobility. She had spontaneous loss of teeth #11, #31, #41, and #46 in the past 2 years. The patient had advanced bone loss despite a minimal amount of bacterial plaque and degree 3 mobility of many teeth. She was diagnosed with type 1 diabetes mellitus on consultation.

![©Cukurova University, Periodontology Dept. Archive](L12 PerioDiabetes_figures/img_9bc2c9e947f84955.webp)
![©Cukurova University, Periodontology Dept. Archive](L12 PerioDiabetes_figures/img_2cd905dcb8156547.webp)
![eFig. 7.111 Two views show the dentition of a 14-year-old girl who was referred with a complaint of tooth mobility. She had spontaneous loss of teeth #11, #31, #41, and #46 in the past 2 years. The patient had advanced bone loss despite a minimal amount of bacterial plaque and degree 3 mobility of many teeth. She was diagnosed with type 1 diabetes mellitus on consultation.](L12 PerioDiabetes_figures/img_281418d236bb3584.webp)</text>
    <formatted_text>**eFig. 7.111** Two views show the dentition of a 14-year-old girl who was referred with a complaint of tooth mobility. She had spontaneous loss of teeth #11, #31, #41, and #46 in the past 2 years. The patient had advanced bone loss despite a minimal amount of bacterial plaque and degree 3 mobility of many teeth. She was diagnosed with type 1 diabetes mellitus on consultation.</formatted_text>
    <images>
      <img bbox="32,18,722,52" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L12 PerioDiabetes_figures/img_9bc2c9e947f84955.webp" caption="©Cukurova University, Periodontology Dept. Archive">
        <description>Clinical intraoral photograph showing the anterior maxillary dentition of a patient exhibiting significant gingival inflammation (redness) and severe tooth mobility/displacement. The central incisors are tilted and crowded.</description>
      </img>
      <img bbox="32,510,722,915" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L12 PerioDiabetes_figures/img_2cd905dcb8156547.webp" caption="©Cukurova University, Periodontology Dept. Archive">
        <description>Dental panoramic radiograph (OPG) showing the mandibular and maxillary arches. The image reveals advanced periodontal bone loss and evidence of spontaneous tooth loss in the anterior regions, consistent with the clinical presentation described in the caption.</description>
      </img>
      <img bbox="32,915,722,990" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="figure" path="L12 PerioDiabetes_figures/img_281418d236bb3584.webp" caption="eFig. 7.111 Two views show the dentition of a 14-year-old girl who was referred with a complaint of tooth mobility. She had spontaneous loss of teeth #11, #31, #41, and #46 in the past 2 years. The patient had advanced bone loss despite a minimal amount of bacterial plaque and degree 3 mobility of many teeth. She was diagnosed with type 1 diabetes mellitus on consultation.">
        <description>Figure caption describing the case study presented in the images above, noting the diagnosis of Type 1 Diabetes Mellitus as a cause for the severe periodontitis symptoms in a 14-year-old female.</description>
      </img>
    </images>
  </page>
  <page number="39">
    <text>**INFLUENCE OF PERIODONTAL DISEASE ON DIABETES**

- Periodontal infection contributes to poorer glycaemic control &amp;amp; increased risk for diabetic complications in diabetics

(Thorstensson et al. 1996; Saremi et al. 2005; Schultis et al. 2007)

![Figure 1](L12 PerioDiabetes_figures/img_b244f4105639a7f3.webp)</text>
    <formatted_text>- Periodontal infection contributes to poorer glycaemic control &amp;amp; increased risk for diabetic complications in diabetics

(Thorstensson et al. 1996; Saremi et al. 2005; Schultis et al. 2007)</formatted_text>
    <images>
      <img bbox="160,286,824,896" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="diagram" path="L12 PerioDiabetes_figures/img_b244f4105639a7f3.webp" caption="Figure 1">
        <description>A complex flowchart illustrating the bidirectional relationship between Periodontitis and Diabetes. The diagram includes labeled boxes for Obesity (orange), Adipokines, RANKL/OPG ratio, AGE/RAGE interaction, Altered PMN function, ROS, Microvascular damage, CVD, PVD, Retinopathy, Nephropathy, Neuropathy, Smoking, Periodontal Microbiota, Citokines (IL-1, IL-6, PGE2, TNF-α), Matrix Metalloproteinases, and Diabetes. Arrows indicate causal or correlational links between these elements.</description>
      </img>
    </images>
  </page>
  <page number="40">
    <text>**Cukurova University, Periodontology Dept. Archive**

**THE UNIVERSITY OF**
**WESTERN**
**AUSTRALIA**

©Cukurova University, Periodontology Dept. Archive
©Cukurova University, Periodontology Dept. Archive

**eFig. 7.112** Three views show alveolar bone loss and severe inflammation with spontaneous bleeding, pus formation, and abscess in a 56-year-old man with *type 2 diabetes* mellitus who used external insulin for 12 years.

![](L12 PerioDiabetes_figures/img_f83c5d2e9b67b485.webp)
![](L12 PerioDiabetes_figures/img_c496c3d1acdcd96e.webp)
![](L12 PerioDiabetes_figures/img_b52021cd0e309fa3.webp)</text>
    <formatted_text>**eFig. 7.112** Three views show alveolar bone loss and severe inflammation with spontaneous bleeding, pus formation, and abscess in a 56-year-old man with *type 2 diabetes* mellitus who used external insulin for 12 years.</formatted_text>
    <images>
      <img bbox="35,24,721,549" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L12 PerioDiabetes_figures/img_f83c5d2e9b67b485.webp">
        <description>Clinical photo showing severe periodontal inflammation with spontaneous bleeding and pus formation in a patient with type 2 diabetes.</description>
      </img>
      <img bbox="35,550,302,916" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L12 PerioDiabetes_figures/img_c496c3d1acdcd96e.webp">
        <description>Close-up clinical photo of an abscess or severe gingival swelling with visible bleeding, demonstrating advanced periodontal disease.</description>
      </img>
      <img bbox="305,550,721,916" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="figure" path="L12 PerioDiabetes_figures/img_b52021cd0e309fa3.webp">
        <description>Dental radiograph (panoramic X-ray) showing alveolar bone loss and severe periodontal destruction consistent with the clinical findings.</description>
      </img>
    </images>
  </page>
  <page number="41">
    <text>**THE UNIVERSITY OF WESTERN AUSTRALIA**

A
©Gukurova University, Periodontology Dept. Archive

B
©Cukurova University, Periodontology Dept. Archive

C
©Gukurova University, Periodontology Dept. Archive

D
©Gukurova University, Periodontology Dept. Archive

**eFig. 7.113** A 28-year-old woman with uncontrolled type 1 **diabetes** mellitus was referred with complaints of rapid mobility of teeth, severe pain, spontaneous pus, and several abscesses. Her fasting glucose level was 486 mg/dL on the day of referral. (A) Although the lesions resembled abscesses of periodontal origin, the pocket depths and attachment levels were within normal levels. (B) The computed tomography findings and consultation with the infection department confirmed the diagnosis of osteomyelitis. (C) View of the patient after 1 week of blood glucose control in the intensive care unit and hyperbaric oxygen therapy. (D) Although the lesions healed uneventfully, severe malocclusion was evident at the 1-year follow-up examination.

![(A)](L12 PerioDiabetes_figures/img_93450ff7d7622a64.webp)
![(B)](L12 PerioDiabetes_figures/img_4546cdcd4916911c.webp)
![(C)](L12 PerioDiabetes_figures/img_e0aef3db4c6b23dc.webp)
![(D)](L12 PerioDiabetes_figures/img_611df1d4a0682b4b.webp)</text>
    <formatted_text>**eFig. 7.113** A 28-year-old woman with uncontrolled type 1 **diabetes** mellitus was referred with complaints of rapid mobility of teeth, severe pain, spontaneous pus, and several abscesses. Her fasting glucose level was 486 mg/dL on the day of referral. (A) Although the lesions resembled abscesses of periodontal origin, the pocket depths and attachment levels were within normal levels. (B) The computed tomography findings and consultation with the infection department confirmed the diagnosis of osteomyelitis. (C) View of the patient after 1 week of blood glucose control in the intensive care unit and hyperbaric oxygen therapy. (D) Although the lesions healed uneventfully, severe malocclusion was evident at the 1-year follow-up examination.</formatted_text>
    <images>
      <img bbox="18,15,346,420" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L12 PerioDiabetes_figures/img_93450ff7d7622a64.webp" caption="(A)">
        <description>Clinical photo showing the patient&amp;apos;s upper and lower dentition. The image highlights severe gingival inflammation with multiple abscesses (pus-filled swellings) on the maxillary anterior gum line. There is a significant gap in the central incisors.</description>
      </img>
      <img bbox="349,15,687,420" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="diagram" path="L12 PerioDiabetes_figures/img_4546cdcd4916911c.webp" caption="(B)">
        <description>Computed tomography (CT) scan cross-section of the jaw. The image shows a large, dark radiolucent lesion (indicating bone loss/infection) in the maxilla, confirming the diagnosis of osteomyelitis mentioned in the text.</description>
      </img>
      <img bbox="18,425,353,829" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L12 PerioDiabetes_figures/img_e0aef3db4c6b23dc.webp" caption="(C)">
        <description>Clinical photo taken after 1 week of treatment. The acute abscesses seen in panel A have resolved, but the gingiva remains red and inflamed. The teeth are still present.</description>
      </img>
      <img bbox="360,425,687,829" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L12 PerioDiabetes_figures/img_611df1d4a0682b4b.webp" caption="(D)">
        <description>Clinical photo at the 1-year follow-up examination. Although the lesions healed uneventfully as stated in the caption, there is severe malocclusion evident due to missing teeth and spacing issues.</description>
      </img>
    </images>
  </page>
  <page number="42">
    <text>![](L12 PerioDiabetes_figures/img_a6f448a7d4f31309.webp)</text>
    <images>
      <img bbox="396,614,750,853" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L12 PerioDiabetes_figures/img_a6f448a7d4f31309.webp">
        <description>Clinical photograph showing a set of dental periodontal instruments (likely explorers or probes) arranged in a row. The handles are wrapped in various colors including grey, purple, pink, blue, green, yellow, orange, and red, while the working ends are metallic.</description>
      </img>
    </images>
  </page>
  <page number="43">
    <text>**THE UNIVERSITY OF WESTERN AUSTRALIA**
EFFECT OF PERIODONTAL TREATMENT IN DIABETICS
•
Limited evidence
Non-surgical periodontal treatment:
•
Short-term studies suggest healing response to be similar in diabetics (well-controlled) compared to non-diabetics
•
Greater risk for relapse in poorly-controlled diabetics

![](L12 PerioDiabetes_figures/img_93c992a9c0c4cc59.webp)</text>
    <formatted_text>#### Non-Surgical Periodontal Treatment

- Limited evidence
- Short-term studies suggest healing response to be similar in diabetics (well-controlled) compared to non-diabetics
- Greater risk for relapse in poorly-controlled diabetics</formatted_text>
    <images>
      <img bbox="598,635,921,938" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L12 PerioDiabetes_figures/img_93c992a9c0c4cc59.webp">
        <description>Clinical photo showing a close-up view of teeth with inflamed red gingiva and plaque accumulation being examined by a dental probe. The image illustrates the subject matter discussed in the text regarding periodontal treatment.</description>
      </img>
    </images>
  </page>
  <page number="44">
    <text>**EFFECT OF PERIODONTAL TREATMENT IN DIABETICS**

*   Limited evidence
Surgical periodontal treatment:
*   Healing response similar in diabetics (well-controlled) compared to non-diabetics
*   But diabetics may have an increased risk for post-surgical infection &amp;amp; impaired wound healing
*   No studies on efficacy of regenerative treatment in diabetics (since they are often excluded in clinical trials)

![](L12 PerioDiabetes_figures/img_da61b1c4a98ca583.webp)</text>
    <formatted_text>#### Surgical Periodontal Treatment

- Limited evidence
- Healing response similar in diabetics (well-controlled) compared to non-diabetics
- But diabetics may have an increased risk for post-surgical infection &amp;amp; impaired wound healing
- No studies on efficacy of regenerative treatment in diabetics (since they are often excluded in clinical trials)</formatted_text>
    <images>
      <img bbox="705,252,996,968" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L12 PerioDiabetes_figures/img_da61b1c4a98ca583.webp">
        <description>Clinical photograph showing a surgical periodontal procedure. The image displays an intraoral view with a dental instrument being used on exposed gingival tissue and a tooth root, illustrating the context of the text regarding healing response and post-surgical infection risks.</description>
      </img>
    </images>
  </page>
  <page number="45">
    <text>INFLUENCE OF
PERIODONTAL
TREATMENT ON
DIABETES
45</text>
    <formatted_text>INFLUENCE OF PERIODONTAL TREATMENT ON DIABETES</formatted_text>
  </page>
  <page number="46">
    <text>&amp;lt;file_utils.image2text:image2text&amp;gt;
INTERVENTION TRIALS
THE UNIVERSITY OF
WESTERN
AUSTRALIA
• More studies (4/7) reported significant benefit
of periodontal treatment
• Improvements in glycaemic control after SRP
+/- adjunctive systemic antibiotics of approx 1%
in HbA1c (eg. 9 to 8%)
42
&amp;lt;/file_utils.image2text&amp;gt;

**INTERVENTION TRIALS**
The University of Western Australia

*   More studies (4/7) reported significant benefit of periodontal treatment
*   Improvements in glycaemic control after SRP +/- adjunctive systemic antibiotics of approx 1% in HbA1c (eg. 9 to 8%)

42

![](L12 PerioDiabetes_figures/img_406dbd65d1531d4f.webp)</text>
    <formatted_text>#### Intervention Trials

- More studies (4/7) reported significant benefit of periodontal treatment
- Improvements in glycaemic control after SRP +/- adjunctive systemic antibiotics of approx 1% in HbA1c (eg. 9 to 8%)</formatted_text>
    <images>
      <img bbox="660,298,915,758" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L12 PerioDiabetes_figures/img_406dbd65d1531d4f.webp">
        <description>Clinical photo showing a dental professional in a white coat and mask performing a procedure on a patient reclined in a dental chair.</description>
      </img>
    </images>
  </page>
  <page number="47">
    <text>**IMPACT OF CHANGE IN HbA1c LEVELS**

**The University of Western Australia**

• UK Prospective Diabetes Study (1993, 1998) showed that every percentage point decrease in HbA1c (eg. 9 to 8%) was associated with 25% reduction in diabetes-related deaths

![Lowering HbA1c Reduces Risk of Diabetic Complications: UKPDS](L12 PerioDiabetes_figures/img_2495ef3d9bf44f37.webp)</text>
    <formatted_text>#### Impact of Change in HbA1c Levels

- UK Prospective Diabetes Study (1993, 1998) showed that every percentage point decrease in HbA1c (eg. 9 to 8%) was associated with 25% reduction in diabetes-related deaths</formatted_text>
    <images>
      <img bbox="368,495,785,910" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="chart" path="L12 PerioDiabetes_figures/img_2495ef3d9bf44f37.webp" caption="Lowering HbA1c Reduces Risk of Diabetic Complications: UKPDS">
        <description>Bar chart titled &amp;apos;Lowering HbA1c Reduces Risk of Diabetic Complications: UKPDS&amp;apos;. The vertical axis represents &amp;apos;Risk reduction (%) per 1% decrease in HbA1c&amp;apos; ranging from 0 to -50. Five colored bars display risk reduction values for specific endpoints: green bar for &amp;apos;Any diabetes endpoint&amp;apos; (-12), orange bar for &amp;apos;Microvascular endpoint&amp;apos; (-25), yellow bar for &amp;apos;Myocardial infarction&amp;apos; (-16), purple bar for &amp;apos;Retinopathy 0-12 years&amp;apos; (-21), and cyan bar for &amp;apos;Albuminuria at 12 years&amp;apos; (-34). Each bar is accompanied by a P-value indicating statistical significance. Source cited at bottom: UK Prospective Diabetes Study Group. Lancet. 1998;352:837-853.</description>
      </img>
    </images>
  </page>
  <page number="48">
    <text>**PERIODONTAL MANAGEMENT OF THE DIABETIC PATIENT**

**The University of Western Australia**

**Educate patients &amp;amp; their physicians:**

*   Diabetes (Type I, II &amp;amp; GDM) can affect periodontal health
*   Depends on diabetic control
*   Uncontrolled diabetics are at higher risk of periodontal destruction &amp;amp; also present with more severe periodontal disease
*   Diabetics have an altered host response to bacteria &amp;amp; poorer healing response
*   Periodontal infections can worsen glycaemic control &amp;amp; increase risk for diabetic complications
*   **2 way relationship**</text>
    <formatted_text>#### Educate Patients &amp;amp; Their Physicians

- Diabetes (Type I, II &amp;amp; GDM) can affect periodontal health
- Depends on diabetic control
- Uncontrolled diabetics are at higher risk of periodontal destruction &amp;amp; also present with more severe periodontal disease
- Diabetics have an altered host response to bacteria &amp;amp; poorer healing response
- Periodontal infections can worsen glycaemic control &amp;amp; increase risk for diabetic complications
- **2 way relationship**</formatted_text>
    <images>
      <img bbox="834,45,970,126" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="logo">
        <description>The official logo of The University of Western Australia, featuring a shield with a swan and open books.</description>
      </img>
    </images>
  </page>
  <page number="49">
    <text>**PERIODONTAL MANAGEMENT OF THE DIABETIC PATIENT**

• Evidence is limited, but with periodontal treatment diabetics heal just as well as non-diabetics
• Disease recurrence may be higher in diabetics especially in patients with uncontrolled diabetes
• **PRA risk assessment – increase frequency of SPT (3/12)**
• Treatment of periodontal infections in diabetics MAY have a significant role in improving glycaemic control &amp;amp; **POTENTIALLY** reduce the burden of diabetic complications

Tervonen et al. 1991; Wesfelt et al. 1996; Tervonen &amp;amp; Karjalainen 1997; Christgau et al. 1998, da Cruz et al. 2008</text>
    <formatted_text>- Evidence is limited, but with periodontal treatment diabetics heal just as well as non-diabetics
- Disease recurrence may be higher in diabetics especially in patients with uncontrolled diabetes
- **PRA risk assessment – increase frequency of SPT (3/12)**
- Treatment of periodontal infections in diabetics MAY have a significant role in improving glycaemic control &amp;amp; **POTENTIALLY** reduce the burden of diabetic complications

Tervonen et al. 1991; Wesfelt et al. 1996; Tervonen &amp;amp; Karjalainen 1997; Christgau et al. 1998, da Cruz et al. 2008</formatted_text>
    <images>
      <img bbox="841,36,975,105" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="logo">
        <description>University logo for The University of Western Australia, featuring the university crest and name in blue text.</description>
      </img>
    </images>
  </page>
  <page number="50">
    <text>**Emerging evidence that diabetics have more chance to develop biological complications (mucositis and peri-implantitis).**

Higher failure rates.

No evidence of contra-indication to implant placement (unless uncontrolled diabetes)

Glycemic control should be maintained.</text>
    <formatted_text>- Emerging evidence that diabetics have more chance to develop biological complications (mucositis and peri-implantitis).
- Higher failure rates.
- No evidence of contra-indication to implant placement (unless uncontrolled diabetes)
- Glycemic control should be maintained.</formatted_text>
    <images>
      <img bbox="759,41,943,128" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="logo">
        <description>The University of Western Australia logo featuring a shield with a swan and the university name.</description>
      </img>
    </images>
  </page>
  <page number="51">
    <text>Wagner *et al*.
**International Journal of Implant Dentistry** (2022) 8:1
https://doi.org/10.1186/s40729-021-00399-8
International Journal of Implant Dentistry
REVIEW
Open Access
Systematic review on diabetes mellitus and dental implants: an update
Juliane Wagner* , Johannes H. Spille, Jörg Wiltfang and Hendrik Naujokat
*
Dental implant procedures represent a safe way of oral rehabilitation in patients with prediabetes or diabetes mellitus, as long as appropriate precautions can be adhered to.
Accordingly, **under controlled conditions there is still no contraindication** for dental implant surgery in patients with diabetes mellitus or prediabetic conditions.
1528 10.1186/s40729-021-00399-8

**©**
THE UNIVERSITY OF
WESTERN AUSTRALIA</text>
    <formatted_text>Wagner *et al*.
**International Journal of Implant Dentistry** (2022) 8:1
https://doi.org/10.1186/s40729-021-00399-8

**REVIEW**

**Systematic review on diabetes mellitus and dental implants: an update**

Juliane Wagner* , Johannes H. Spille, Jörg Wiltfang and Hendrik Naujokat

- Dental implant procedures represent a safe way of oral rehabilitation in patients with prediabetes or diabetes mellitus, as long as appropriate precautions can be adhered to.
- Accordingly, **under controlled conditions there is still no contraindication** for dental implant surgery in patients with diabetes mellitus or prediabetic conditions.</formatted_text>
    <images>
      <img bbox="760,43,935,124" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="logo">
        <description>The University of Western Australia logo featuring a shield with a swan and the university name.</description>
      </img>
    </images>
  </page>
  <page number="52">
    <text># Our lecture today…</text>
    <formatted_text>Our lecture today…</formatted_text>
    <images>
      <img bbox="754,36,948,126" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="logo">
        <description>The official logo of The University of Western Australia. It features a shield containing three open books above a black swan (the university&amp;apos;s mascot) on a yellow background, with the motto &amp;apos;Sine die&amp;apos; visible below the shield.</description>
      </img>
    </images>
  </page>
  <page number="53">
    <text>Thank you!!!

THE UNIVERSITY OF WESTERN AUSTRALIA

SEEK WISDOM</text>
    <formatted_text>Thank you!!!

THE UNIVERSITY OF WESTERN AUSTRALIA

SEEK WISDOM</formatted_text>
    <images>
      <img bbox="58,749,346,921" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="logo">
        <description>The University of Western Australia institutional logo featuring a shield with a swan and books, alongside the text &amp;apos;THE UNIVERSITY OF WESTERN AUSTRALIA&amp;apos; and the motto &amp;apos;SEEK WISDOM&amp;apos;.</description>
      </img>
    </images>
  </page>
  <footnotes>[^1]: Original PDF page 1: [[L12 PerioDiabetes.pdf#page=1|L12 PerioDiabetes, p.1]]
[^2]: Original PDF page 2: [[L12 PerioDiabetes.pdf#page=2|L12 PerioDiabetes, p.2]]
[^3]: Original PDF page 3: [[L12 PerioDiabetes.pdf#page=3|L12 PerioDiabetes, p.3]]
[^4]: Original PDF page 4: [[L12 PerioDiabetes.pdf#page=4|L12 PerioDiabetes, p.4]]
[^5]: Original PDF page 5: [[L12 PerioDiabetes.pdf#page=5|L12 PerioDiabetes, p.5]]
[^6]: Original PDF page 6: [[L12 PerioDiabetes.pdf#page=6|L12 PerioDiabetes, p.6]]
[^7]: Original PDF page 7: [[L12 PerioDiabetes.pdf#page=7|L12 PerioDiabetes, p.7]]
[^8]: Original PDF page 8: [[L12 PerioDiabetes.pdf#page=8|L12 PerioDiabetes, p.8]]
[^9]: Original PDF page 9: [[L12 PerioDiabetes.pdf#page=9|L12 PerioDiabetes, p.9]]
[^10]: Original PDF page 10: [[L12 PerioDiabetes.pdf#page=10|L12 PerioDiabetes, p.10]]
[^11]: Original PDF page 11: [[L12 PerioDiabetes.pdf#page=11|L12 PerioDiabetes, p.11]]
[^12]: Original PDF page 12: [[L12 PerioDiabetes.pdf#page=12|L12 PerioDiabetes, p.12]]
[^13]: Original PDF page 13: [[L12 PerioDiabetes.pdf#page=13|L12 PerioDiabetes, p.13]]
[^14]: Original PDF page 14: [[L12 PerioDiabetes.pdf#page=14|L12 PerioDiabetes, p.14]]
[^15]: Original PDF page 15: [[L12 PerioDiabetes.pdf#page=15|L12 PerioDiabetes, p.15]]
[^16]: Original PDF page 16: [[L12 PerioDiabetes.pdf#page=16|L12 PerioDiabetes, p.16]]
[^17]: Original PDF page 17: [[L12 PerioDiabetes.pdf#page=17|L12 PerioDiabetes, p.17]]
[^18]: Original PDF page 18: [[L12 PerioDiabetes.pdf#page=18|L12 PerioDiabetes, p.18]]
[^19]: Original PDF page 19: [[L12 PerioDiabetes.pdf#page=19|L12 PerioDiabetes, p.19]]
[^20]: Original PDF page 20: [[L12 PerioDiabetes.pdf#page=20|L12 PerioDiabetes, p.20]]
[^21]: Original PDF page 21: [[L12 PerioDiabetes.pdf#page=21|L12 PerioDiabetes, p.21]]
[^22]: Original PDF page 22: [[L12 PerioDiabetes.pdf#page=22|L12 PerioDiabetes, p.22]]
[^23]: Original PDF page 23: [[L12 PerioDiabetes.pdf#page=23|L12 PerioDiabetes, p.23]]
[^24]: Original PDF page 24: [[L12 PerioDiabetes.pdf#page=24|L12 PerioDiabetes, p.24]]
[^25]: Original PDF page 25: [[L12 PerioDiabetes.pdf#page=25|L12 PerioDiabetes, p.25]]
[^26]: Original PDF page 26: [[L12 PerioDiabetes.pdf#page=26|L12 PerioDiabetes, p.26]]
[^27]: Original PDF page 27: [[L12 PerioDiabetes.pdf#page=27|L12 PerioDiabetes, p.27]]
[^28]: Original PDF page 28: [[L12 PerioDiabetes.pdf#page=28|L12 PerioDiabetes, p.28]]
[^29]: Original PDF page 29: [[L12 PerioDiabetes.pdf#page=29|L12 PerioDiabetes, p.29]]
[^30]: Original PDF page 30: [[L12 PerioDiabetes.pdf#page=30|L12 PerioDiabetes, p.30]]
[^31]: Original PDF page 31: [[L12 PerioDiabetes.pdf#page=31|L12 PerioDiabetes, p.31]]
[^32]: Original PDF page 32: [[L12 PerioDiabetes.pdf#page=32|L12 PerioDiabetes, p.32]]
[^33]: Original PDF page 33: [[L12 PerioDiabetes.pdf#page=33|L12 PerioDiabetes, p.33]]
[^34]: Original PDF page 34: [[L12 PerioDiabetes.pdf#page=34|L12 PerioDiabetes, p.34]]
[^35]: Original PDF page 35: [[L12 PerioDiabetes.pdf#page=35|L12 PerioDiabetes, p.35]]
[^36]: Original PDF page 36: [[L12 PerioDiabetes.pdf#page=36|L12 PerioDiabetes, p.36]]
[^37]: Original PDF page 37: [[L12 PerioDiabetes.pdf#page=37|L12 PerioDiabetes, p.37]]
[^38]: Original PDF page 38: [[L12 PerioDiabetes.pdf#page=38|L12 PerioDiabetes, p.38]]
[^39]: Original PDF page 39: [[L12 PerioDiabetes.pdf#page=39|L12 PerioDiabetes, p.39]]
[^40]: Original PDF page 40: [[L12 PerioDiabetes.pdf#page=40|L12 PerioDiabetes, p.40]]
[^41]: Original PDF page 41: [[L12 PerioDiabetes.pdf#page=41|L12 PerioDiabetes, p.41]]
[^42]: Original PDF page 42: [[L12 PerioDiabetes.pdf#page=42|L12 PerioDiabetes, p.42]]
[^43]: Original PDF page 43: [[L12 PerioDiabetes.pdf#page=43|L12 PerioDiabetes, p.43]]
[^44]: Original PDF page 44: [[L12 PerioDiabetes.pdf#page=44|L12 PerioDiabetes, p.44]]
[^45]: Original PDF page 45: [[L12 PerioDiabetes.pdf#page=45|L12 PerioDiabetes, p.45]]
[^46]: Original PDF page 46: [[L12 PerioDiabetes.pdf#page=46|L12 PerioDiabetes, p.46]]
[^47]: Original PDF page 47: [[L12 PerioDiabetes.pdf#page=47|L12 PerioDiabetes, p.47]]
[^48]: Original PDF page 48: [[L12 PerioDiabetes.pdf#page=48|L12 PerioDiabetes, p.48]]
[^49]: Original PDF page 49: [[L12 PerioDiabetes.pdf#page=49|L12 PerioDiabetes, p.49]]
[^50]: Original PDF page 50: [[L12 PerioDiabetes.pdf#page=50|L12 PerioDiabetes, p.50]]
[^51]: Original PDF page 51: [[L12 PerioDiabetes.pdf#page=51|L12 PerioDiabetes, p.51]]
[^52]: Original PDF page 52: [[L12 PerioDiabetes.pdf#page=52|L12 PerioDiabetes, p.52]]
[^53]: Original PDF page 53: [[L12 PerioDiabetes.pdf#page=53|L12 PerioDiabetes, p.53]]</footnotes>
</document>
